Xenon (XENE) - Kompaniyaning xususiy kapitali

Ommaviy kompaniya Xenon (XENE) logotipi

Xenon Pharmaceuticals (XENE) hozirda epilepsiyaga qarshi dori vositalarini tijoriy ravishda chiqarishdan oldin ularning sinovlarining yakuniy bosqichlarini yakunlashga e'tibor qaratmoqda. Biznes markaziy nerv tizimi patologiyalariga qarshi kurashish uchun yetakchi nevrologik markazlar bilan ilmiy ittifoqlarga tayanadi va 1.25 ko'rsatkichi umumiy manzarani to'ldiradi. Quyida ko'rsatilgan narx harakati global sog'liqni saqlash gigantlari bilan hamkorlik yangi molekulalarning tasdiqlanishini tezlashtirayotganini va kuchli ilmiy sinergiyani yaratayotganini tasdiqlaydi.

XENE Xenon Balans kapitallashuvi (04.07.2022 - 29.10.2026)

Xenon (XENE) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kursi Xenon Corp|XENE - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Xenon Pharmaceuticals Inc.|XENE - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Xenon Pharmaceuticals|XENE - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti xenon-pharma.com|XENE - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Xenon Pharmaceuticals|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Xenon Pharmaceuticals Inc.|XENE - Kompaniya qarzlari|Balans qiymatiga qarzlar Xenon Pharmaceuticals Inc.|XENE - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzdorligi Xenon Pharmaceuticals
Kompaniyaning jamlanma tahlili:Xenon Pharmaceuticals
Xenon Pharmaceuticals Inc. yetakchi tovari

Balans qiymati barcha majburiyatlar ayirib tashlangan sof kapital qiymatini ifodalaydi va har bir aksiyaning haqiqiy aktivlar bilan ta'minlanganligini aks ettiradi. Kompaniyaning balans qiymati tarixini tahlil qilish orqali investor Xenon Pharmaceuticals (XENE) moliyaviy barqarorligini baholaydi, bunda ushbu aktivning barqarorligi kompaniyaning neyroterapevtik mahsulotlar ishlab chiqilishini tezlashtirish uchun robotlashtirilgan skrining va AI modellashtirishni kengaytirish qobiliyatini tasdiqlaydi.

Asosiy raqobatchilar

BIIB - Buxgalteriya kapitallashuvi|Balans kapitallashuvi NBIX|RGC (regencellbioscience.com) - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Viking Pharma - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Supernus Corp SUPN|Kompaniyaning sof aktivlari CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati AMLX|Kompaniyaning xususiy kapitali Trevi Corp|Kompaniyaning sof aktivlari Praxis Precision Medicines (PRAX)|Buxgalteriya kapitallashuvi anavex.com|CeriBell - Balans kapitallashuvi|Kompaniyaning xususiy kapitali PRTA (Prothena Corporation)|ALEC - Kompaniyaning balans qiymati|Annexon Biosciences Inc. - Buxgalteriya kapitallashuvi|OMER (Omeros Corp.) - Kompaniyaning balans qiymati|NGNE: Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati AC Immune SA|Buxgalteriya kapitallashuvi Voyager Therapeutics Inc|NMRA - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati SCLX|TVGN - Kompaniyaning balans qiymati|Sof aktivlar qiymati alphacognition.com (ACOG)|Balans kapitallashuvi Cognition Therapeutics|Kompaniyaning buxgalteriya qiymati Inhibikase Therapeutics Inc IKT|Cassava - Balans kapitallashuvi|ASRT: Balans kapitallashuvi|Kompaniyaning balans qiymati coyatherapeutics.com COYA|VTGN (Vistagen) - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati OVID|Kompaniyaning sof aktivlari Acumen Pharmaceuticals Inc.|Balans kapitallashuvi CRVO|Balans kapitallashuvi alteritytherapeutics.com (ATHE)|Clene - Balans kapitallashuvi|Kompaniyaning sof aktivlari PepGen Inc PEPG|JUNS (Jupiter Neurosciences Inc) - Balans kapitallashuvi|Relmada Therapeutics Inc (RLMD) - Kompaniyaning xususiy kapitali|ANVS: Kompaniyaning sof aktivlari|Balans kapitallashuvi Grace Therapeutics|Firefly Neuroscience, Inc (AIFF) - Kompaniyaning sof aktivlari|Jami sof aktivlar ANEW Medical, Inc.|NRSN (NeuroSense Therapeutics) - Balans kapitallashuvi|Biznesning balans bahosi Reviva Pharmaceuticals Holdings Inc. (RVPH)|MetaVia - Balans kapitallashuvi|Kompaniyaning sof aktivlari NeurAxis Inc NRXS|Helius Medical Technologies Inc. - Balans kapitallashuvi|PASG: Balans kapitallashuvi|bionomics.com.au (NEUP) - Kompaniyaning balans qiymati|NERV (Minerva Neurosciences Inc) - Kompaniyaning balans qiymati|ATHA: Kompaniyaning balans qiymati|Biznesning balans bahosi Addex (ADXN)|Kompaniyaning sof aktivlari Alzamend Neuro, Inc. ALZN|Buxgalteriya kapitallashuvi cyclerion.com (CYCN)|PTIX: Balans kapitallashuvi|Pasithea Therapeutics Corp - Kompaniyaning xususiy kapitali|Cortigent Medical (CRGT) - Kompaniyaning balans qiymati|ATXI - Buxgalteriya kapitallashuvi|Balans kapitallashuvi BCLI|CARA (caratherapeutics.com) - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Chromocell Therapeutics Corp. (CHRO)|Buxgalteriya kapitallashuvi Eliem|Intra-Cellular Therapies - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Longboard LBPH|Kompaniyaning sof aktivlari MRNS (Marinus Pharmaceuticals)|nkgenbiotech.com - Balans kapitallashuvi|Kompaniyaning balans qiymati NeuroBo Pharmaceuticals, Inc. (NRBO)|SAGE: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati SNPX|Kompaniyaning xususiy kapitali Trevena Inc|Kompaniyaning sof aktivlari Vigil Neuroscience Inc. (VIGL)|Buxgalteriya kapitallashuvi Anew Medical Inc.|Cerevel Therapeutics, Inc. - Balans kapitallashuvi